TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
MNKD

MannKind Corp

Healthcare · Biotechnology

3.30$ +1.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

MannKind Corp (MNKD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 109 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement MNKD
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
162 12 3.0 2.2 2.0 4.5 3.5 3.9 4.5 16 17 15 15 16 16 15 15 18 17 23 22 13 12 19 33 36 41 49 51 58 66 72 70 77 78 77 82 112 90 109 394
27 12 2.5 5.1 4.6 5.0 4.0 5.1 5.3 6.1 5.6 6.5 8.9 7.0 7.5 5.7 5.2 6.3 7.6 9.9 9.9 11 11 13 17 16 16 14 14 18 19 20 18 20 18 21 20 24 22 30 96
135 0.6 0.5 -2.9 -2.5 -0.5 -0.5 -1.2 -0.8 10.0 12 8.5 5.7 9.0 8.7 9.5 10 12 9.8 13 12 1.1 1.0 6.0 15 20 24 34 37 40 48 52 52 57 61 56 62 88 68 80 298
3.9 1.6 3.1 3.1 4.4 3.5 2.6 3.0 2.0 1.1 1.7 1.6 1.6 2.0 1.8 1.5 1.5 1.5 2.4 2.3 3.7 3.9 3.5 4.9 4.1 7.2 5.6 6.5 10.0 9.2 10 12 13 11 11 14 14 28 17 18 77
6.1 6.5 15 19 18 23 21 22 19 18 26 17 17 16 14 14 14 17 17 20 17 31 8.0 10 9.1 32 11 12 11 9.5 11 13 11 34 25 32 14 58 54 58 185
17 15 19 22 22 27 23 25 21 19 27 18 18 20 16 17 19 36 16 24 19 25 22 26 25 33 30 33 32 33 31 35 39 31 39 51 43 96 71 80 290
118 -12 -20 -32 -28 -29 -27 -21 -22 -7.7 -14 -11 -8.8 -11 -7.1 -7.9 -9.1 -24 -6.2 -10 -6.6 -24 -21 -20 -9.6 -13 -6.0 1.7 5.1 7.9 17 17 13 26 22 5.3 19 -7.7 -3.0 -0.4 7.8
4.9 3.7 3.4 3.1 3.5 3.2 2.9 2.8 2.1 1.7 1.7 1.7 5.3 2.3 2.3 2.4 2.4 2.4 6.5 3.2 2.8 4.1 5.1 9.1 5.3 5.3 5.2 9.3 5.3 5.4 9.3 13 8.4 7.5 11 6.2 7.3 13 12 12 45
127 54 -16 -35 -33 -33 -30 -22 -24 -9.8 -15 -12 -10 -14 -9.3 -10 -11 -26 -13 -36 -4.4 -28 -26 -29 -14 -18 -9.8 -5.3 1.7 3.0 11 -1.7 13 8.4 14 0.9 7.8 -21 -16 -19 -49
4.9 2.7 3.4 3.1 3.5 0.1 2.9 0.2 2.1 1.2 1.7 1.7 5.3 0.6 2.3 2.4 -0.2 1.6 6.2 3.2 2.8 4.1 5.1 9.1 5.3 5.3 6.2 7.7 5.6 1.6 0.3 0.3 1.3 1.0 0.5 0.3 -0.2 -5.0 0.3 -0.1 -5.0
127 54 -16 -35 -33 -33 -30 -23 -24 -9.8 -15 -12 -10 -14 -9.3 -10 -11 -26 -13 -36 -4.4 -28 -26 -29 -14 -18 -9.8 -5.3 1.7 1.4 11 -2.0 12 7.4 13 0.7 8.0 -16 -17 -19 -44
132 -14 -12 -32 -29 -29 -27 -19 -22 -7.7 -12 -10 -4.4 -11 -6.2 -7.0 -8.3 -23 -5.5 -31 -0.5 -22 -20 -17 -7.8 -11 -3.2 5.6 8.4 9.9 22 13 24 19 27 9.7 18 -2.5 2.5 13 31

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?